Yüklüyor......
Pharmacogenomics of Lithium Response in Bipolar Disorder
Despite being the most widely studied mood stabilizer, researchers have not confirmed a mechanism for lithium’s therapeutic efficacy in Bipolar Disorder (BD). Pharmacogenomic applications may be clinically useful in the future for identifying lithium-responsive patients and facilitating personalized...
Kaydedildi:
| Yayımlandı: | Pharmaceuticals (Basel) |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
MDPI
2021
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8063790/ https://ncbi.nlm.nih.gov/pubmed/33804842 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ph14040287 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|